Status:

COMPLETED

Sternalock Versus Wires for Sternal Closure Study

Lead Sponsor:

University of Melbourne

Collaborating Sponsors:

Zimmer Biomet

Conditions:

Cardiac Surgery

Sternal Closure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Design: Investigator Initiated Prospective Randomised Trial Study Centre's: Melbourne Private Hospital Royal Melbourne Hospital Study Hypothesis: Use of the SternaLock 360 will reduce the inciden...

Detailed Description

Introduction/Background Information Since the inception of cardiac surgery in the early 1960s, division of the sternum has provided the superior access to cardiac structures. Cardiac surgery may invol...

Eligibility Criteria

Inclusion

  • Age ≥ 18 year old Elective cardiac surgery Primary cardiac surgical procedure No evidence of infection at time of surgery Sufficient English language to complete the Postoperative Quality of Recovery Survey

Exclusion

  • Previous sternotomy (redo) Clinical sternal deformity Home locality preventing follow-up (e.g. remote regional, interstate or overseas patient)

Key Trial Info

Start Date :

October 5 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 25 2018

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03282578

Start Date

October 5 2017

End Date

November 25 2018

Last Update

April 17 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Melbourne Private Hospital

Melbourne, Victoria, Australia, 3050